The GSN Gene Amyloidosis Finnish type genetic test is a specialized diagnostic procedure designed to identify mutations in the GSN gene, which are responsible for the development of Finnish type amyloidosis. This rare form of amyloidosis is characterized by the accumulation of abnormal amyloid proteins in various tissues of the body, leading to a wide range of symptoms including kidney problems, nerve damage, and heart issues. The test is particularly relevant for individuals of Finnish descent or those with a family history of the condition, as it can provide crucial information for early diagnosis and management.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab. The sample is then analyzed using advanced genetic sequencing techniques to detect any mutations in the GSN gene. The results of this test can help guide treatment decisions and allow for the implementation of preventive measures to manage symptoms and improve the quality of life for affected individuals.
The cost of the GSN Gene Amyloidosis Finnish type genetic test at DNA Labs UAE is 4400 AED. This price reflects the complexity of the genetic analysis and the specialized expertise required to accurately interpret the results. Patients considering this test should consult with a healthcare provider or a genetic counselor to understand its benefits and limitations in the context of their personal health history and family background.
The CHGB Gene Amyotrophic Lateral Sclerosis Risk Factor Genetic Test is a specialized diagnostic tool designed to assess an individual's genetic predisposition to Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. This test specifically focuses on mutations in the CHGB gene, which have been associated with an increased risk of developing ALS. Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, this test offers a comprehensive evaluation for individuals concerned about their genetic risk for ALS. The test is priced at 4400 AED and provides valuable insights, enabling individuals to make informed decisions about their health and potentially guiding future medical management and lifestyle adjustments in consultation with healthcare professionals.
The SOD1 Gene Amyotrophic Lateral Sclerosis Type 1 Genetic Test is a specialized diagnostic tool used to identify mutations in the SOD1 gene, which are linked to the development of Amyotrophic Lateral Sclerosis (ALS) type 1. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord, leading to muscle weakness and, eventually, severe disability. The SOD1 gene plays a crucial role in encoding a protein that protects the body from damage caused by free radicals. Mutations in this gene can lead to the dysfunction of motor neurons, contributing to the onset of ALS.
This genetic test is conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, and analyzing it to detect any abnormalities in the SOD1 gene that may indicate a predisposition to ALS type 1. The process is designed to be straightforward and minimally invasive, with results that can provide crucial information for individuals with a family history of ALS or those exhibiting symptoms of the disease.
The cost of the SOD1 Gene Amyotrophic Lateral Sclerosis Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full analysis and a comprehensive report that explains the findings. The test is an invaluable resource for those seeking early detection and intervention strategies, potentially offering individuals and their families peace of mind and the ability to plan for the future with a better understanding of their genetic health landscape.
The TARDBP gene, known for its role in encoding the TAR DNA-binding protein 43 (TDP-43), has been closely linked with Amyotrophic Lateral Sclerosis (ALS), specifically identified as ALS type 10. This form of ALS is characterized by its genetic origin, where mutations in the TARDBP gene lead to the development of the disease. The TDP-43 protein is crucial for the regulation of gene expression in the nervous system and its mutation can result in the progressive neurodegenerative disorder that ALS is known for, affecting motor neurons and leading to severe physical disability over time.
To diagnose and potentially predict the risk of developing ALS type 10, genetic testing targeting the TARDBP gene is available. DNA Labs UAE offers this specialized test, providing a crucial tool for individuals with a family history of ALS or those experiencing early symptoms of motor neuron diseases. The test involves analyzing the individual's DNA to identify mutations in the TARDBP gene that are associated with ALS type 10.
The cost of the TARDBP Gene Amyotrophic Lateral Sclerosis Type 10 Genetic Test at DNA Labs UAE is 4400 AED. This test is not only significant for diagnosis but also for family planning and understanding the risk of ALS in future generations. It is a critical step in the management and understanding of ALS, offering hope and information to affected individuals and their families.
The FIG4 gene plays a critical role in the development and function of nerve cells, and mutations in this gene have been associated with Amyotrophic Lateral Sclerosis type 11 (ALS11), a subtype of ALS. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe disability.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the FIG4 gene that are linked to ALS11. This test is crucial for individuals with a family history of ALS or those experiencing symptoms suggestive of the disease, as it can provide a definitive diagnosis of ALS11. Early diagnosis is vital for the management of the condition and for informing patients and their families about the progression of the disease, potential treatment options, and genetic counseling.
The cost of the FIG4 gene test for Amyotrophic Lateral Sclerosis type 11 at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the FIG4 gene. The results of this test can help guide clinical decisions and enable a personalized approach to the management of ALS11.
The OPTN Gene Amyotrophic Lateral Sclerosis Type 12 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, aimed at identifying mutations in the OPTN gene, which are linked to the development of Amyotrophic Lateral Sclerosis (ALS) Type 12. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability.
This genetic test is crucial for individuals with a family history of ALS or those showing symptoms of the disease, as it can provide a definitive diagnosis of ALS Type 12. Early detection through genetic testing allows for better management of the condition, including planning for treatment and supportive care.
The test involves a simple blood draw or a cheek swab, which is then analyzed in the state-of-the-art facilities of DNA Labs UAE. The laboratory employs cutting-edge technology to accurately identify mutations in the OPTN gene, ensuring reliable results.
The cost of the OPTN Gene Amyotrophic Lateral Sclerosis Type 12 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be understated, as it opens the door to targeted treatments and interventions that can significantly improve the quality of life for those affected by this challenging condition.
The "VCP Gene Amyotrophic Lateral Sclerosis Type 14 Genetic Test" is a specialized diagnostic procedure aimed at detecting mutations in the VCP gene, which are associated with a rare form of Amyotrophic Lateral Sclerosis (ALS), known as type 14. This condition, a neurodegenerative disorder, leads to the progressive loss of muscle control, severely impacting patients' quality of life.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test is crucial for individuals with a family history of ALS or those exhibiting symptoms suggestive of the disease. By identifying specific genetic alterations in the VCP gene, the test not only aids in the accurate diagnosis of ALS type 14 but also helps in understanding the risk of developing the condition, facilitating early intervention and management strategies.
The cost of the VCP Gene Amyotrophic Lateral Sclerosis Type 14 Genetic Test is set at 4400 AED. This investment covers the sophisticated techniques and expert analysis required to detect the genetic markers associated with this form of ALS, offering patients and their families critical insights into their genetic health and guiding healthcare professionals in tailoring personalized treatment plans.
The SIGMAR1 gene, associated with Amyotrophic Lateral Sclerosis type 16 (ALS16), plays a crucial role in the understanding and diagnosis of this specific form of ALS. Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability.
The genetic test for ALS16 focuses on mutations within the SIGMAR1 gene. Identifying these mutations can be pivotal for families with a history of ALS, as it provides crucial information regarding the inheritance pattern, potential risks to other family members, and contributes to the body of knowledge necessary for future therapeutic developments.
DNA Labs UAE offers this specialized genetic testing service. The test is priced at 4400 AED and is conducted in their state-of-the-art laboratory facilities. By opting for this test at DNA Labs UAE, patients and their families can expect a comprehensive analysis of the SIGMAR1 gene, which will aid in the diagnosis of ALS16. This information can be invaluable for making informed decisions about treatment options and managing the disease more effectively.
The CHMP2B Gene Amyotrophic Lateral Sclerosis Type 17 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CHMP2B gene that are linked to Amyotrophic Lateral Sclerosis (ALS) Type 17. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to loss of muscle control. Type 17 ALS, associated with mutations in the CHMP2B gene, is a rare form of the disease that can be familial or sporadic. This genetic test plays a crucial role in the early detection and diagnosis of ALS Type 17, enabling healthcare professionals to devise appropriate management and treatment plans for affected individuals. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test is priced at 4400 AED. The accurate identification of CHMP2B gene mutations through this test is vital for understanding the disease's progression, potential familial risk, and exploring targeted therapeutic strategies.
The PFN1 Gene Amyotrophic Lateral Sclerosis Type 18 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the PFN1 gene, which have been associated with the development of Amyotrophic Lateral Sclerosis (ALS) type 18. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability. The test aims to provide crucial genetic information for individuals who have a family history of ALS or are exhibiting symptoms of the disease, enabling early diagnosis and the opportunity for better management of the condition. The cost of the test is 4400 AED, reflecting the specialized technology and expertise required to accurately identify the genetic variations linked to this form of ALS. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test represents a significant step forward in the personalized care and management of ALS, offering hope and vital information to patients and their families.
